PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
-2.59%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$1.33B
AUM Growth
+$1.33B
(-5.3%)
Cap. Flow
+$73.5M
Cap. Flow
% of AUM
5.54%
Top 10 Holdings %
Top 10 Hldgs %
38.03%
Holding
288
New
61
Increased
32
Reduced
61
Closed
45
Top Buys
| 1 |
LivaNova
LIVN
|
$40.9M |
| 2 |
WM Technology
MAPS
|
$23.4M |
| 3 |
Seer Inc
SEER
|
$20.9M |
| 4 |
Cooper Companies
COO
|
$16.5M |
| 5 |
CANO
Cano Health, Inc.
CANO
|
$16.2M |
Top Sells
| 1 |
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
|
$54.7M |
| 2 |
Intellia Therapeutics
NTLA
|
$23.2M |
| 3 |
Organogenesis Holdings
ORGO
|
$21.3M |
| 4 |
Eli Lilly
LLY
|
$15.1M |
| 5 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$14.5M |
Sector Composition
| 1 | Healthcare | 82.38% |
| 2 | Consumer Staples | 1.98% |
| 3 | Technology | 1.76% |
| 4 | Industrials | 1.72% |
| 5 | Materials | 1.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
26
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $13.7M | 0.42% | 5,859,812 +1,394,073 | +31% | +$3.26M |
|
|
APR
27
DELISTED
Apria, Inc. Common Stock
APR
| $13.2M | 0.4% | 355,465 -344,255 | -49% | -$12.8M |
|
|
SLGC
28
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $12.9M | 0.39% | +1,037,645 | New | +$12.9M |
|
|
CNVY
29
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $12M | 0.37% | +1,429,946 | New | +$12M |
|
30
Apyx Medical
APYX
$75.3M
| $11.9M | 0.36% | 857,018 -95,027 | -10% | -$1.32M |
|
31
Agilon Health
AGL
$530M
| $11.7M | 0.36% | 447,402 +63,457 | +17% | +$1.66M |
|
32
Codexis
CDXS
$246M
| $11.1M | 0.34% | 476,170 -7,797 | -2% | -$181K |
|
|
OCDX
33
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $10.2M | 0.31% | +550,000 | New | +$10.2M |
|
34
Privia Health
PRVA
$2.83B
| $9.86M | 0.3% | 418,613 +72,569 | +21% | +$1.71M |
|
35
Cytek Biosciences
CTKB
$527M
| $9.51M | 0.29% | +444,368 | New | +$9.51M |
|
36
Zimmer Biomet
ZBH
$21B
| $9.51M | 0.29% | 65,000 +15,000 | +30% | +$2.2M |
|
37
10x Genomics
TXG
$1.74B
| $9.27M | 0.28% | 63,661 -976 | -2% | -$142K |
|
38
Personalis
PSNL
$434M
| $9.23M | 0.28% | 479,651 +4,643 | +1% | +$89.3K |
|
39
AMN Healthcare
AMN
$796M
| $9.18M | 0.28% | +80,000 | New | +$9.18M |
|
40
Haemonetics
HAE
$2.63B
| $9.18M | 0.28% | +130,000 | New | +$9.18M |
|
41
Stereotaxis
STXS
$261M
| $9.03M | 0.27% | 1,678,638 +226,292 | +16% | +$1.22M |
|
|
OLK
42
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $8.8M | 0.27% | 362,746 +71,468 | +25% | +$1.73M |
|
43
Adaptive Biotechnologies
ADPT
$2.01B
| $8.7M | 0.26% | 255,916 -47,116 | -16% | -$1.6M |
|
44
Ginkgo Bioworks
DNA
$750M
| $8.69M | 0.26% | +750,000 | New | +$8.69M |
|
45
Pacific Biosciences
PACB
$393M
| $8.69M | 0.26% | 340,143 -131,634 | -28% | -$3.36M |
|
46
Lantheus
LNTH
$3.73B
| $8.65M | 0.26% | 336,926 -199,946 | -37% | -$5.13M |
|
47
NeoGenomics
NEO
$1.13B
| $8.58M | 0.26% | +177,778 | New | +$8.58M |
|
48
Alpha Teknova
TKNO
$231M
| $8.56M | 0.26% | 344,041 -5,959 | -2% | -$148K |
|
49
Evolent Health
EVH
$1.12B
| $8.53M | 0.26% | +275,000 | New | +$8.53M |
|
50
GH Research
GHRS
$837M
| $8.38M | 0.26% | 380,045 -19,955 | -5% | -$440K |
|